Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02705105
Title Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kyowa Hakko Kirin Pharma, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Gilbert Arizona 85234 United States Details
Greenbrae California 94904 United States Details
Los Angeles California 90033 United States Details
Jacksonville Florida 32224 United States Details
Augusta Georgia 30912 United States Details
Chicago Illinois 60637 United States Details
Baltimore Maryland 21205 United States Details
Kalamazoo Michigan 49007 United States Details
Piscataway New Jersey 08854 United States Details
Albuquerque New Mexico 87106 United States Details
Goldsboro North Carolina 27534 United States Details
Columbus Ohio 43210 United States Details
Portland Oregon 97213 United States Details
Philadelphia Pennsylvania 19111-2497 United States Details
Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field